Shanghai Kinetic Medical Co., Ltd

Total Valuation

Shanghai Kinetic Medical Co., Ltd carries a market capitalization of 4.34B, placing it among publicly traded companies globally. Its enterprise value stands at 2.67B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Shanghai Kinetic Medical Co., Ltd currently has 717.03M shares outstanding.

Valuation Ratios

Shanghai Kinetic Medical Co., Ltd trades at a trailing price-to-earnings ratio of 24.45. The price-to-sales ratio is 3.32, and the price-to-book ratio stands at 1.84.

Enterprise Valuation

On an enterprise value basis, Shanghai Kinetic Medical Co., Ltd trades at an EV/EBITDA multiple of 22.11 and an EV/FCF ratio of 26.17. The EV/Sales ratio of 2.53 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.11 provides insight into valuation relative to core operating earnings.

Financial Position

Shanghai Kinetic Medical Co., Ltd maintains a current ratio of 4.61, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.88, indicating elevated leverage, while an interest coverage ratio of 13.43 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Shanghai Kinetic Medical Co., Ltd has paid -17.07M in income taxes, reflecting an effective tax rate of 31.47.

Stock Price Statistics

Shanghai Kinetic Medical Co., Ltd's stock has gained approximately 14.15094% over the past 52 weeks. The 50-day moving average sits at 6.58, while the 200-day moving average is 6.15.

Income Statement

Over the trailing twelve months, Shanghai Kinetic Medical Co., Ltd generated 1.05B in revenue and converted that into -91.99M in net income, yielding earnings per share of -0.13. EBITDA reached 120.66M, while operating income came in at 120.66M.

Balance Sheet

Shanghai Kinetic Medical Co., Ltd holds 1.24B in cash and equivalents against 311.40M in total debt, resulting in a net debt position of -52.52M. Total book value stands at 1.90B, with working capital of 1.46B providing operational flexibility.

Cash Flow

After subtracting -94.36M in capital expenditures, free cash flow totaled -94.36M - equivalent to -0.13 per share.

Margins

Shanghai Kinetic Medical Co., Ltd operates with a gross margin of 50.43, reflecting its pricing power and cost economics. The operating margin of 11.44 and net profit margin of -8.72 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -51.13 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Shanghai Kinetic Medical Co., Ltd's most recent stock split took place on October 21, 2016 with a 125000:224239 split ratio.

Scores

Shanghai Kinetic Medical Co., Ltd posts an Altman Z-Score of 6.10, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.